Alnylam Pharmaceuticals Inc - Company Profile

Powered by

All the data and insights you need on Alnylam Pharmaceuticals Inc in one report.

  • Save hours of research time and resources with
    our up-to-date Alnylam Pharmaceuticals Inc Strategy Report

  • Understand Alnylam Pharmaceuticals Inc position in the market,
    performance and strategic initiatives.

  • Gain competitive edge and increase your
    chances of success

Back to companies

Alnylam Pharmaceuticals Inc: Premium Databases

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Alnylam Pharmaceuticals Clinical Trials

Determine Alnylam Pharmaceuticals Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of Alnylam Pharmaceuticals Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 90+ results.
Deserunt mollit sunt Lorem GDCTWXYZ Lorem Lorem Lorem WXYZ Planned Pfizer Inc
A Phase I Study of ALN-TTRsc04 in Healthy Volunteers GDCT0470840 ALNTTRSC-04 Metabolic Disorders Amyloidosis Phase I Planned Alnylam Pharmaceuticals Inc
Expanded Access Protocol to Provide Patisiran to Patients With Transthyretin-mediated Amyloidosis With Cardiomyopathy GDCT0463906 patisiran Metabolic Disorders Amyloid Cardiomyopathy Phase III Ongoing, recruiting Alnylam Pharmaceuticals Inc
A Phase III Study Cemdisiran in Immunoglobulin a Nephropathy (IgAN) GDCT0462463 cemdisiran Genito Urinary System And Sex Hormones IgA Nephropathy (Berger's Disease) Phase III Planned Alnylam Pharmaceuticals Inc
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Gain a 360-degree view of Alnylam Pharmaceuticals Inc and make more informed decisions for your business
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Start of HubSpot Embed Code End of HubSpot Embed Code